Senores Pharma Closes Trading Window for Insider Trading Rules

Senores Pharmaceuticals Ltd has announced the closure of its trading window for directors, promoters, designated persons, and their immediate relatives. This closure is in compliance with SEBI PIT Regulations and the company's code of conduct for preventing insider trading. The window will be shut from October 01, 2026, until 48 hours after the declaration of the un-audited financial results for the quarter and half-year ending September 30, 2026. All concerned individuals are advised against trading in the company's securities during this period. The date for the board meeting to approve these financial results will be communicated separately.